| Net income/(loss) | 28.61M |
| Depreciation and intangible asset amortization expense | 10.72M |
| Amortization of development costs | |
| Amortization of debt fees and other | 1.55M |
| Impairment charge | 0 |
| Equity in losses of investment in unconsolidated affiliate | |
| Share-based compensation expense | 1.17M |
| Deferred taxes | 1K |
| Expense associated with convertible debt exchange | |
| Non-cash convertible debt interest expense | |
| Accounts receivable | -113.68M |
| Inventories | -8.65M |
| Deferred catalog costs | 3.96M |
| Prepaid expenses and other current assets | |
| Accounts payable | 24.22M |
| Accrued liabilities | 10.75M |
| Net cash used in operating activities | |
| Additions to property, plant and equipment | -9.61M |
| Investment in product development costs | |
| Net cash used in investing activities | |
| Proceeds from bank borrowings | 258.79M |
| Repayment of debt and capital leases | |
| Payment of debt fees and other | 0 |
| Net cash provided by/(used in) financing activities | |
| Net decrease in cash and cash equivalents | -5.52M |
| Cash and cash equivalents, beginning of period | 12.87M |
| Cash and cash equivalents, end of period | 7.35M |
| Interest paid | 10.4M |
| Income taxes paid | 1.29M |